X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs UNICHEM LAB - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD UNICHEM LAB LUPIN LTD/
UNICHEM LAB
 
P/E (TTM) x 29.2 -33.5 - View Chart
P/BV x 2.8 0.7 384.6% View Chart
Dividend Yield % 0.6 2.3 25.5%  

Financials

 LUPIN LTD   UNICHEM LAB
EQUITY SHARE DATA
    LUPIN LTD
Mar-18
UNICHEM LAB
Mar-18
LUPIN LTD/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,465382 383.5%   
Low Rs727234 310.6%   
Sales per share (Unadj.) Rs349.6116.3 300.6%  
Earnings per share (Unadj.) Rs5.6-18.9 -29.4%  
Cash flow per share (Unadj.) Rs29.6-11.7 -251.9%  
Dividends per share (Unadj.) Rs5.005.00 100.0%  
Dividend yield (eoy) %0.51.6 28.1%  
Book value per share (Unadj.) Rs300.3381.0 78.8%  
Shares outstanding (eoy) m452.0870.34 642.7%   
Bonus/Rights/Conversions ESOPSBB-  
Price / Sales ratio x3.12.6 118.4%   
Avg P/E ratio x197.2-16.3 -1,211.3%  
P/CF ratio (eoy) x37.1-26.2 -141.2%  
Price / Book Value ratio x3.60.8 451.4%  
Dividend payout %90.0-26.4 -340.4%   
Avg Mkt Cap Rs m495,50221,668 2,286.8%   
No. of employees `00017.02.3 747.5%   
Total wages/salary Rs m28,6472,006 1,427.8%   
Avg. sales/employee Rs Th9,273.63,587.8 258.5%   
Avg. wages/employee Rs Th1,681.0880.0 191.0%   
Avg. net profit/employee Rs Th147.4-583.7 -25.3%   
INCOME DATA
Net Sales Rs m158,0428,180 1,932.0%  
Other income Rs m1,504610 246.4%   
Total revenues Rs m159,5458,790 1,815.0%   
Gross profit Rs m31,475-1,320 -2,384.1%  
Depreciation Rs m10,859505 2,149.8%   
Interest Rs m2,04480 2,551.2%   
Profit before tax Rs m20,076-1,295 -1,549.9%   
Minority Interest Rs m-710-   
Prior Period Items Rs m35-2 -1,600.0%   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,88533 8,631.4%   
Profit after tax Rs m2,513-1,331 -188.8%  
Gross profit margin %19.9-16.1 -123.4%  
Effective tax rate %14.4-2.6 -556.9%   
Net profit margin %1.6-16.3 -9.8%  
BALANCE SHEET DATA
Current assets Rs m122,09523,318 523.6%   
Current liabilities Rs m50,9564,635 1,099.3%   
Net working cap to sales %45.0228.4 19.7%  
Current ratio x2.45.0 47.6%  
Inventory Days Days85122 69.5%  
Debtors Days Days120121 98.7%  
Net fixed assets Rs m129,8768,163 1,591.0%   
Share capital Rs m904141 642.6%   
"Free" reserves Rs m134,86626,660 505.9%   
Net worth Rs m135,77126,801 506.6%   
Long term debt Rs m64,2453 1,946,818.2%   
Total assets Rs m263,05431,890 824.9%  
Interest coverage x10.8-15.2 -71.3%   
Debt to equity ratio x0.50 384,297.4%  
Sales to assets ratio x0.60.3 234.2%   
Return on assets %1.7-3.9 -44.2%  
Return on equity %1.9-5.0 -37.3%  
Return on capital %3.7-4.5 -81.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53,1414,356 1,219.8%   
Fx outflow Rs m19,3350-   
Net fx Rs m33,8074,356 776.0%   
CASH FLOW
From Operations Rs m17,512-1,123 -1,558.8%  
From Investments Rs m-14,07316,487 -85.4%  
From Financial Activity Rs m-14,921-8,811 169.3%  
Net Cashflow Rs m-11,4826,552 -175.2%  

Share Holding

Indian Promoters % 46.6 50.1 93.0%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 15.1 74.8%  
FIIs % 31.9 3.0 1,063.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 31.7 31.9%  
Shareholders   98,259 20,176 487.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   PFIZER  GSK PHARMA  PLETHICO PHARMA  WYETH LTD  ABBOTT INDIA  

Compare LUPIN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Finish Flat; IT and Pharma Stocks Witness Selling(Closing)

Share markets in India ended their trading session on a flattish note. Sectoral indices ended on a mixed note with stocks in the IT sector and pharma sector witnessing most of the selling pressure.

Related Views on News

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Nov 14, 2018 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS